FI906008A0 - Förfarande för stabilisering av en vattenhaltig blandning av heterocyklisk förening - Google Patents

Förfarande för stabilisering av en vattenhaltig blandning av heterocyklisk förening

Info

Publication number
FI906008A0
FI906008A0 FI906008A FI906008A FI906008A0 FI 906008 A0 FI906008 A0 FI 906008A0 FI 906008 A FI906008 A FI 906008A FI 906008 A FI906008 A FI 906008A FI 906008 A0 FI906008 A0 FI 906008A0
Authority
FI
Finland
Prior art keywords
methionine
stabilizing
heterocyclic compound
stabilized
aqueous mixture
Prior art date
Application number
FI906008A
Other languages
English (en)
Finnish (fi)
Other versions
FI97689C (sv
FI97689B (sv
FI906008A (sv
Inventor
Den Oetelaar Petrus Johann Van
Maria Martina Francisc Mentink
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI906008A0 publication Critical patent/FI906008A0/sv
Publication of FI906008A publication Critical patent/FI906008A/sv
Application granted granted Critical
Publication of FI97689B publication Critical patent/FI97689B/sv
Publication of FI97689C publication Critical patent/FI97689C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI906008A 1989-12-06 1990-12-05 Förfarande för stabilisering av en vattenhaltig blandning av heterocyklisk förening FI97689C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89203092 1989-12-06
EP89203092 1989-12-06

Publications (4)

Publication Number Publication Date
FI906008A0 true FI906008A0 (sv) 1990-12-05
FI906008A FI906008A (sv) 1991-06-07
FI97689B FI97689B (sv) 1996-10-31
FI97689C FI97689C (sv) 1997-02-10

Family

ID=8202518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906008A FI97689C (sv) 1989-12-06 1990-12-05 Förfarande för stabilisering av en vattenhaltig blandning av heterocyklisk förening

Country Status (15)

Country Link
US (1) US5082864A (sv)
EP (1) EP0431663B1 (sv)
JP (1) JP2977912B2 (sv)
KR (1) KR0185377B1 (sv)
AT (1) ATE99943T1 (sv)
AU (1) AU628768B2 (sv)
CA (1) CA2030773C (sv)
DE (1) DE69005992T2 (sv)
DK (1) DK0431663T3 (sv)
ES (1) ES2062310T3 (sv)
FI (1) FI97689C (sv)
IE (1) IE63985B1 (sv)
NZ (1) NZ236332A (sv)
PT (1) PT96096B (sv)
ZA (1) ZA909568B (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1591H (en) * 1992-10-09 1996-09-03 Fulcher; John Preparation of flavor-enhanced reduced calorie fried foods
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
TW587938B (en) * 1997-03-27 2004-05-21 Akzo Nobel Nv Pharmaceutical composition for the treatment and/or prophylaxis of psychotic disorder
WO1999051237A1 (en) * 1998-04-02 1999-10-14 Akzo Nobel N.V. Oral liquid antidepressant solution
US6211171B1 (en) 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
ES2296893T3 (es) * 2001-02-12 2008-05-01 N.V. Organon Uso de mirtazapina para el tratamiento de la depresion severa en un paciente humano y portador del gen de la apolipoproteina e4.
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
DK2316456T3 (en) 2003-04-29 2017-09-11 Orexigen Therapeutics Inc Compositions for affecting weight loss comprising an opioid antagonist and bupropion
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
EP1734955A2 (en) * 2004-01-13 2006-12-27 Duke University Compositions of an anticonvulsant and an antipsychotic drug for affecting weigt loss
WO2006023702A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders with setiptiline
WO2006031720A2 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
ES2402522T3 (es) * 2005-11-22 2013-05-06 Orexigen Therapeutics, Inc. Composiciones y procedimientos para aumentar la sensibilidad a la insulina
CA2637359A1 (en) * 2006-01-17 2007-07-26 The Regents Of The University Of Colorado Central administration of stable formulations of therapeutic agents for cns conditions
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20170077291A (ko) 2006-11-09 2017-07-05 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
KR101735466B1 (ko) 2006-11-09 2017-05-15 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
JP2011521973A (ja) * 2008-05-30 2011-07-28 オレキシジェン・セラピューティクス・インコーポレーテッド 内臓脂肪の状態を処置するための方法
CN102724878A (zh) 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
LT3730132T (lt) 2012-06-06 2022-08-25 Nalpropion Pharmaceuticals Llc Kompozicija, skirta panaudoti pacientų su didele širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde
KR101652081B1 (ko) 2014-12-30 2016-08-30 김인호 전극보일러 급탕시스템
EP3261645B1 (en) 2015-02-27 2021-04-28 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
KR20170001494A (ko) 2015-06-26 2017-01-04 김인호 전극보일러 전류제어시스템
CN108853042B (zh) * 2018-09-20 2021-03-26 北京哈三联科技有限责任公司 一种米氮平冻干口崩片及其制备方法和应用
GR1009883B (el) * 2019-06-07 2020-12-11 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν υδροχλωρικη νορτριπτυλινη

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
DE3247676A1 (de) * 1982-12-23 1984-06-28 A. Nattermann & Cie GmbH, 5000 Köln Galenische form fuer amitriptylinoxid und verfahren zur herstellung

Also Published As

Publication number Publication date
DE69005992D1 (de) 1994-02-24
US5082864A (en) 1992-01-21
PT96096B (pt) 1998-02-27
ZA909568B (en) 1991-09-25
AU6779890A (en) 1991-06-13
FI97689C (sv) 1997-02-10
CA2030773C (en) 2001-07-24
KR0185377B1 (ko) 1999-05-01
FI97689B (sv) 1996-10-31
IE904226A1 (en) 1991-06-19
FI906008A (sv) 1991-06-07
DK0431663T3 (da) 1994-03-07
IE63985B1 (en) 1995-06-28
ES2062310T3 (es) 1994-12-16
KR910011250A (ko) 1991-08-07
EP0431663A1 (en) 1991-06-12
AU628768B2 (en) 1992-09-17
EP0431663B1 (en) 1994-01-12
ATE99943T1 (de) 1994-01-15
JPH05262651A (ja) 1993-10-12
CA2030773A1 (en) 1991-06-07
DE69005992T2 (de) 1994-05-05
NZ236332A (en) 1992-07-28
PT96096A (pt) 1991-09-30
JP2977912B2 (ja) 1999-11-15

Similar Documents

Publication Publication Date Title
FI906008A0 (sv) Förfarande för stabilisering av en vattenhaltig blandning av heterocyklisk förening
DK659689A (da) Fremgangsmaade til fremstilling af farvede, stabiliserede blegemiddelaktivatorekstrudater og vaskemiddel omfattende samme
DE3686410D1 (de) Stabilisierte zusammensetzungen von menschlichen aktivatoren des gewebeplasminogens.
DK506587D0 (da) Imidderivater
DK0675717T3 (da) Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin
DK160876C (da) Imidazoquinoxalinforbindelser, fremgangsmaade til deres fremstilling, anvendelse af forbindelserne og farmaceutiske praeparater, hvori forbindelserne indgaar
ATE40823T1 (de) Verwendung von loesungsmitteln bei der herstellung von s-triazinderivaten und verfahren zur herstellung von s-triazinderivaten.
DK288287D0 (da) Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
DK583188A (da) Farmaceutiske praeparater indeholdende ergolin-derivatet pergolid og fremgangsmaade til stabilisering af saadanne praeparater
DE68905414D1 (de) 2-substituierte paraaminophenole und ihre verwendung fuer die faerbung von keratinischen fasern.
NO903430D0 (no) Fremgangsmaate for fremstilling av aminoketonderivater.
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
SE7514294L (sv) 4,4'-bis-/2",4"-bis-(diisopropanolamino)-s-triazin-6"-ylamino/-stilben-2,2'-disulfonsyra, dess framstellning och dess anvendning som optiskt vithetsforhojande medel
FI870994A0 (fi) Foerfarande foer framstaellning av stabila, injekterbara farmaceutiska kompositioner, vilka innehaoller 1,4-dihydroxi-5,8-bis/2-(2-hydroxietylamino)etylamino/ antrakinondihydroklorid.
DK165689C (da) 1,5-disubstituerede imidazolderivater, fremgangsmaade til fremstilling af saadanne forbindelser, fungicidt praeparat indeholdende saadanne forbindelser samt anvendelse af saadanne forbindelser som fungicider
PT84011B (pt) Processo para a preparacao de novos analogos de compostos polipeptidicos e hipocalcificantes e de composicoes farmaceuticas que os contem
NO904961L (no) Glutarsyrederivater, samt fremstilling derav.
FI903950A0 (fi) Ny komposition.
DE69004138D1 (de) Mit einer Cyanogruppe substituierte Nitroanilin-Farbstoffe.
PT95972A (pt) Processo de preparacao de novos compostos de imidazoquinoxalina e de composicoes farmaceuticas que os contem
DK661388A (da) Fremgangsmaade til fremstilling af thiophenforbindelser
DK0925785T3 (da) Stabiliseret farmaceutisk præparat indeholdende dopamin eller dobutamin
DE3772926D1 (de) Verfahren zur stabilisierung von procaterol.
DK104691A (da) Cykliske imidatestere til anvendelse som udgangsmateriale ved fremstillling af 1,4-dihydropyrid-5-yl-(cyklisk imidat)estere
CO4650015A1 (es) Plaguicidas derivados de hidrazina

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AKZO N.V.

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON